Antibodies that recognize and block SARS-CoV-2 infection have the potential to be powerful weapons. An infectious disease expert explains what antibodies are and how they could be used as a therapy.
Academic rigor, journalistic flair
Articles on Monoclonal antibodies
Displaying 21 - 26 of 26 articles
The Ebola virus claimed 11,000 lives in 2014. Today, scientists may have cured the disease in guinea pigs by using antibodies.
A new preventive drug for migraines was approved recently by the FDA. Here’s how it works, and how others in the pipeline might be able to help the millions who suffer from migraines.
2018 looks set to be the year we finally get effective treatments for migraine.
Using the right metaphor in science is important.
Why it’s important to fund blue-skies research.
Top contributors
-
Assistant Professor of Infectious Diseases, University of Virginia
-
Emeritus Professor, Brunel University London
-
Professor of Medicine, University of Virginia
-
Visiting Research Fellow, History of Biomedical Sciences, University of Cambridge
-
Regents' Professor & Chair, Medical Laboratory Science, Texas State University
-
Assistant Professor of Medicine, University of Pittsburgh
-
Assistant Professor of Neurology, University of Florida
-
Postdoctoral Researcher in the MRC Human Immunology Unit, Weatherall Institute of Molecular Medicine, University of Oxford
-
Assistant Professor of Medicine, University of Pittsburgh
-
Associate Professor of Medicine, Epidemiology and Clinical and Translational Science, University of Pittsburgh
-
Principal Investigator of Infectious Diseases, U.S. Army Medical Research Institute of Infectious Diseases
-
Professor of Medicine and Director, Center for Antibody Therapeutics, University of Pittsburgh
-
Paediatric Respiratory Physician, and Honorary Fellow Manager, Murdoch Children's Research Institute
-
Professor of Molecular Immunology, University of Oxford
-
Assistant Professor of Emergency Medicine, Albert Einstein College of Medicine
